Drug Trial News

RSS
Baylor Scott & White Research Institute enrolls first patients in NIH ACTIV-3 clinical trial

Baylor Scott & White Research Institute enrolls first patients in NIH ACTIV-3 clinical trial

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

Vaccine 'nationalism' will slow coronavirus fight if poor countries are left exposed

DHODH inhibitor PTC299 shows potential as a COVID-19 therapeutic

DHODH inhibitor PTC299 shows potential as a COVID-19 therapeutic

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Speed of Novavax vaccine development does not compromise quality of the SARS-CoV-2 immunogen

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

New document includes practical resources to improve diversity and inclusion in clinical research

New document includes practical resources to improve diversity and inclusion in clinical research

Vitamin D does not reduce risk of depression or mood changes

Vitamin D does not reduce risk of depression or mood changes

Panthera’s oncology clinical trial sites in the UK are open for research activities

Panthera’s oncology clinical trial sites in the UK are open for research activities

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

ACTG initiates novel clinical trial to evaluate multiple therapeutics for COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

NIH trial to evaluate potential new therapeutics for mild, moderate COVID-19

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Clinical trial to test safety, efficacy of antibody treatment in hospitalized COVID-19 patients

Broad range of therapeutics are being evaluated for Parkinson's disease

Broad range of therapeutics are being evaluated for Parkinson's disease

Oxford University and ZOE join forces to widen access to COVID-19 treatment trials

Oxford University and ZOE join forces to widen access to COVID-19 treatment trials

Dexamethasone should be a standard drug in severe COVID-19

Dexamethasone should be a standard drug in severe COVID-19

The race to a coronavirus vaccine

The race to a coronavirus vaccine

Harbour BioMed and Viva Biotech announce strategic collaboration to promote incubation of biotech startups

Harbour BioMed and Viva Biotech announce strategic collaboration to promote incubation of biotech startups

Investigational drug shows promising results for treating HNSCC tumors

Investigational drug shows promising results for treating HNSCC tumors

Women receiving treatment for cancers are not at increased of being hospitalized for COVID-19

Women receiving treatment for cancers are not at increased of being hospitalized for COVID-19